| Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation. | |
| | |
MedLine Citation:
|
PMID: 19815173 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A 61 years old male patient having the complaint of angina pectoris underwent coronary angiography that revealed critical luminal stenosis at left anterior descending artery (LAD) and diagonal branch. Percutaneous transluminal coronary angioplasty was performed and sirolimus eluting stents (CYPHER; Johnson & Johnson--Cordis) 2.75 x 10 mm and 2.75 x 10 mm were deployed respectively. One year after the procedure coronary angiography revealed coronary artery aneurysm (CAA) formation in diagonal branch and mild ectasia in LAD stent area. Last coronary angiography four years and three months after initial intervention showed multiple CAA at diagonal branch and LAD. This case report is an example of late formation of CAA by sirolimus-coated coronary stent. |
| | |
Authors:
|
Kenan Ov?n?; Hikmet Yorgun; Necla Ozer |
Related Documents
:
|
16197833 - Preliminary evidence supporting the safety of drug-eluting stents in neurovascular dise... 15136903 - Incidence of stenotic lesions predicted by acute phase changes in coronary arterial dia... 7105173 - New technique for retrograde left heart catheterization in aortic stenosis. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Cardiovascular revascularization medicine : including molecular interventions Volume: 10 ISSN: 1878-0938 ISO Abbreviation: Cardiovasc Revasc Med Publication Date: 2009 Oct-Dec |
Date Detail:
|
Created Date: 2009-10-09 Completed Date: 2010-01-06 Revised Date: 2010-04-23 |
Medline Journal Info:
|
Nlm Unique ID: 101238551 Medline TA: Cardiovasc Revasc Med Country: United States |
Other Details:
|
Languages: eng Pagination: 252-4 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Hacettepe University, Ankara, Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary
/
adverse effects*,
instrumentation* Cardiovascular Agents / administration & dosage* Coronary Aneurysm / etiology*, radiography Coronary Angiography Coronary Stenosis / radiography, therapy* Drug-Eluting Stents* Humans Male Middle Aged Severity of Illness Index Sirolimus / administration & dosage* Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Cardiovascular Agents; 53123-88-9/Sirolimus |
| Comments/Corrections | |
Erratum In:
|
Cardiovasc Revasc Med. 2010 Jan-Mar;11(1):69 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Biomaterial optimization in a percutaneous aortic valve stent using finite element analysis.
Next Document: Funneling: enhancing results of small-vessel stenting.